Posted 11/4/2021 10:19 AM (GMT -5)
Isn’t there always?
Apart from the math debate, what about gradual enlargement from BPH as a source of the PSA progression?
Perhaps a course of Avodart over some months to somewhat shrink the prostate and reduce the PSA. Then, if the PSA continues the upward progression, it would be much more indicative of PCa and may warrant a biopsy.
Groundhogy, what is the estimate of the prostate size? Any symptoms or changes in urinary habits like urgency, flow and or voiding differences, or nocturia? What are the DRE findings? Have you had DRE with each PSA test? Have there been differences felt?
With relatively low PSA and no reported DRE abnormalities, a biopsy, to me seems possibly premature. A benign 35cc prostate would be expected to express a PSA of about 2.31 on average. Your PSA is a bit higher than that. By the same calculation your current expression would indicate a volume of more like 50cc more indicative of BPH. However, let’s assume a 35cc prostate with some G6 expressing that additional 1.0 of PSA would indicate tumor volume of about 0.2 to 0.3cc. That is very small to find with a biopsy or MRI. Now if you reported that your prostate was only 20cc (small), then the calculations would be much more indicative of PCa as the source and better indicate the biopsy. At your PSA, assuming a normal or small prostate, an abnormal DRE with a felt nodule, should prompt a biopsy. As would changes in the DRE over the past few years.
I would do a bit more investigating before a biopsy. Also understand that most third party payors won’t spring for a more expensive saturation biopsy until you have had one or more negative TRUS biopsies. So check on that.
Keep searching…..the truth is out there……